Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell Transplantation

Shernan Holtan, MD, Todd E. DeFor, MS, Armin Rashidi, MD PhD, Alexander Khoruts, MD, Christopher Staley, PhD, Lucie M Turcotte, MD, Pamala A. Jacobson, PharmD, Daniel J. Weisdorf, MD, Margaret L. MacMillan, MD

Blood (2019) 134 (Supplement_1): 39.

https://doi.org/10.1182/blood-2019-129236

Published: 2019

Journal Articles

ST2 and Rg3a As a Biomarker for Predicting of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Hakan Goker, MDPROF., Elifcan Aladag, MD, Yahya Buyukasik, MD, Nelson J. Chao, MD, Umit Akman, Bio., Haluk Demiroglu, MDPROF.

Blood (2019) 134 (Supplement_1): 5684.

https://doi.org/10.1182/blood-2019-121682

Published: 2019

Journal Articles

Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis

Tapan M. Kadia, MD, Hongbing Ma, MD PhD, Ke Zeng, MD PhD, Mitsutaka Nishimoto, MD PhD, Mi-Ae Lyu, PhD, Meixian Huang, Musa Yilmaz, MD, Courtney D. DiNardo, MDMSc, Ghayas C. Issa, MD, Simrit Parmar, MBBS, Swami P. Iyer, MD, Parameswaran Hari, MBBS, MD, Naval G. Daver, MD, Elias Jabbour, MD, Gautam M. Borthakur, MD, Srdan Verstovsek, MD PhD

Blood (2019) 134 (Supplement_1): 1221.

https://doi.org/10.1182/blood-2019-127702

Published: 2019

Journal Articles

A Biomarker Signature to Predict Complete Response to Itacitinib and Corticosteroids in Acute Graft Versus Host Disease

Michael A. Pratta, MSc, Hao Liu, PhD, Sherry Owens, PhD, Ying Yan, PhD, Michael C. Arbushites, Michael D. Howell, PhD

Blood (2019) 134 (Supplement_1): 3279.

https://doi.org/10.1182/blood-2019-124069

Published: 2019

Journal Articles

Plasma Biomarker Association with Response in Acute GVHD Subjects Treated with the Combination of Itacitinib and Corticosteroids in a Phase 1 Clinical Trial

Michael A. Pratta, MSc, Hao Liu, PhD, Michael C. Arbushites, Robert C Newton, PhD, Michael D. Howell, PhD

Blood (2018) 132 (Supplement 1): 4559.

https://doi.org/10.1182/blood-2018-99-116330

Published: 2018

Journal Articles

Potential of Plasmatic Biomarkers to Predict Acute Gvhd Severity: A Validation Study in a Prospective Cohort of 177 Patients

Marie Robin, MD PhD, Raphael Porcher, PhD, Laetitia Taurines, Bastien Oriano, Regis Peffault De Latour, MD PhD, Flore Sicre De Fontbrune, MD, David Michonneau, MD PhD, Nathalie Dhedin, MD, Christine Chomienne, MD PhD, Gérard Socié, MDPhD, Marie-Hélène Schlageter, PharmD

Blood (2017) 130 (Supplement 1): 4480.

https://doi.org/10.1182/blood.V130.Suppl_1.4480.4480

Published: 2017

Journal Articles

REG3A Polymorphism Is Associated with the Incidence of Extensive Chronic Gvhd after Allogeneic BMT

Daisuke Koyama, MD, Makoto Murata, MD PhD, Ryo Hanajiri, MD PhD, Shingo Okuno, MD, Sonoko Kamoshita, MD, Jakrawadee Julamanee, MD, Erina Takagi, MD, Kotaro Miyao, MD, Reona Sakemura, MD, Tatsunori Goto, MD, Aika Seto, MD, Yukiyasu Ozawa, MD PhD, Koichi Miyamura, MD PhD, Seitaro Terakura, MD PhD, Tetsuya Nishida, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2016) 128 (22): 3426.

https://doi.org/10.1182/blood.V128.22.3426.3426

Published: 2016

Journal Articles

High Day 28 ST2 Biomarker Levels Predict Severe Day 100 Acute Graft-Versus-Host Disease and Day 180 Transplant-Related Mortality After Double-Unit Cord Blood Transplantation

Doris M Ponce, MD, Patrick Hilden, MS, Christy Mumaw, MS, Sean Devlin, PhD, Marissa N Lubin, BA, Katherine L Evans, BA, Susan Prockop, MD, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Sergio A Giralt, MD, Marcel R.M. van den Brink, MD, PhD, Sophie Paczesny, MD, PhD, Juliet N Barker, MBBS, (Hons), FRACP

Blood (2013) 122 (21): 146.

https://doi.org/10.1182/blood.V122.21.146.146

Published: 2013

Journal Articles

High Plasma Level Of Regenerating Islet-Derived 3-Alpha (Reg3a) Protein Predicts Grade 3-4 Lower Gastrointestinal Acute Graft-Versus-Host Disease and Poor Prognosis

Aining Sun, Chengsen Cai, Guanghua Chen, MD, Jun Wang, Wu Depei

Blood (2013) 122 (21): 4602.

https://doi.org/10.1182/blood.V122.21.4602.4602

Published: 2013

Journal Articles

Identification of Differentially Expressed Genes in the Rituximab- Resistant Clone (Ramos RR1) Compared to Wildtype Sensitive Ramos: Therapeutic Implications in Rituximab-Resistance

Stavroula Baritaki, PhD, Jose Rodriguez, Gustavo Helguera, PhD, Melisa Martinez-Paniagua, Mario Vega, PhD, Sara Huerta-Yepez, PhD., Ali Jazirehi, PhD, Demetrios Spandidos, PhD, Manuel L Penichet, M.D., Ph.D., Benjamin Bonavida, PhD

Blood (2008) 112 (11): 3770.

https://doi.org/10.1182/blood.V112.11.3770.3770

Published: 2008

NARROW

Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell Transplantation

ST2 and Rg3a As a Biomarker for Predicting of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis

A Biomarker Signature to Predict Complete Response to Itacitinib and Corticosteroids in Acute Graft Versus Host Disease

Plasma Biomarker Association with Response in Acute GVHD Subjects Treated with the Combination of Itacitinib and Corticosteroids in a Phase 1 Clinical Trial

Potential of Plasmatic Biomarkers to Predict Acute Gvhd Severity: A Validation Study in a Prospective Cohort of 177 Patients

REG3A Polymorphism Is Associated with the Incidence of Extensive Chronic Gvhd after Allogeneic BMT

High Day 28 ST2 Biomarker Levels Predict Severe Day 100 Acute Graft-Versus-Host Disease and Day 180 Transplant-Related Mortality After Double-Unit Cord Blood Transplantation

High Plasma Level Of Regenerating Islet-Derived 3-Alpha (Reg3a) Protein Predicts Grade 3-4 Lower Gastrointestinal Acute Graft-Versus-Host Disease and Poor Prognosis

Identification of Differentially Expressed Genes in the Rituximab- Resistant Clone (Ramos RR1) Compared to Wildtype Sensitive Ramos: Therapeutic Implications in Rituximab-Resistance

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only